Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peer Tfelt-Hansen

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Ugeskrift for Laeger|January 16, 2007
[Cluster headache (Horton's headache)]Peer Tfelt-Hansen, Rigmor Højland Jensen
Ugeskrift for Laeger|June 8, 2006
[Triptanes in the treatment of migraine. A review based on three Cochrane reviews]Peer Tfelt-Hansen, Helle K Iversen
Cephalalgia : an International Journal of Headache|September 9, 2020
Onset of action in placebo-controlled migraine attacks trials: A literature review and recommendationPeer Tfelt-Hansen, Hans-Christoph Diener
CNS Drugs|October 12, 2007
Over-the-counter triptans for migraine : what are the implications?Peer Tfelt-Hansen, Timothy J Steiner
Central Nervous System Agents in Medicinal Chemistry|September 1, 2012
Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the futureDimos D Mitsikostas, Peer Tfelt-Hansen
Headache|April 5, 2016
The Evidence for Prescription Information for Possible Use of a Repeated Dose of Oral Triptans: A CommentPeer Tfelt-Hansen, Stine F Jespersen
Headache|January 8, 2009
Verapamil for cluster headache. Clinical pharmacology and possible mode of actionPeer Tfelt-Hansen, Jacob Tfelt-Hansen
Headache|April 12, 2019
Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic MigraineTimothy J Steiner, Peer Tfelt-Hansen
Cephalalgia : an International Journal of Headache|July 15, 2020
Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacksPeer Tfelt-Hansen, Hans-Christoph Diener
Ugeskrift for Laeger|November 9, 2012
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?]Rikke Marie Jensen, Peer Tfelt-Hansen
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Ugeskrift for Laeger|January 16, 2007
[Cluster headache (Horton's headache)]Peer Tfelt-Hansen, Rigmor Højland Jensen
Ugeskrift for Laeger|June 8, 2006
[Triptanes in the treatment of migraine. A review based on three Cochrane reviews]Peer Tfelt-Hansen, Helle K Iversen
Cephalalgia : an International Journal of Headache|September 9, 2020
Onset of action in placebo-controlled migraine attacks trials: A literature review and recommendationPeer Tfelt-Hansen, Hans-Christoph Diener
CNS Drugs|October 12, 2007
Over-the-counter triptans for migraine : what are the implications?Peer Tfelt-Hansen, Timothy J Steiner
Central Nervous System Agents in Medicinal Chemistry|September 1, 2012
Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the futureDimos D Mitsikostas, Peer Tfelt-Hansen
Headache|April 5, 2016
The Evidence for Prescription Information for Possible Use of a Repeated Dose of Oral Triptans: A CommentPeer Tfelt-Hansen, Stine F Jespersen
Headache|January 8, 2009
Verapamil for cluster headache. Clinical pharmacology and possible mode of actionPeer Tfelt-Hansen, Jacob Tfelt-Hansen
Headache|April 12, 2019
Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic MigraineTimothy J Steiner, Peer Tfelt-Hansen
Cephalalgia : an International Journal of Headache|July 15, 2020
Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacksPeer Tfelt-Hansen, Hans-Christoph Diener
Ugeskrift for Laeger|November 9, 2012
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?]Rikke Marie Jensen, Peer Tfelt-Hansen
Pageof 11